{"id":15827,"date":"2024-05-26T07:57:35","date_gmt":"2024-05-26T07:57:35","guid":{"rendered":"https:\/\/longevityhealthplans.com\/?p=15827"},"modified":"2024-05-26T07:57:38","modified_gmt":"2024-05-26T07:57:38","slug":"terapia-hormonal-en-poblaciones-pediatricas-guias-y-controversias","status":"publish","type":"post","link":"https:\/\/longevityhealthplans.com\/es\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/","title":{"rendered":"Terapia Hormonal en Poblaciones Pedi\u00e1tricas: Gu\u00edas y Controversias"},"content":{"rendered":"<p class=\"wp-block-paragraph\">La terapia hormonal en poblaciones pedi\u00e1tricas es un tema que combina un potencial terap\u00e9utico prometedor con complejidades \u00e9ticas y m\u00e9dicas significativas. Implica la administraci\u00f3n de hormonas para tratar afecciones como trastornos del crecimiento, pubertad precoz y disforia de g\u00e9nero. A pesar de sus beneficios, la terapia hormonal en ni\u00f1os y adolescentes sigue siendo controvertida debido a los posibles impactos a largo plazo en el desarrollo y la salud.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pautas para la Terapia Hormonal Pedi\u00e1trica<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Las gu\u00edas m\u00e9dicas para la terapia hormonal en poblaciones pedi\u00e1tricas est\u00e1n dise\u00f1adas para garantizar la seguridad y la eficacia. En trastornos del crecimiento, como la deficiencia de hormona del crecimiento, se recomienda com\u00fanmente la administraci\u00f3n de hormona de crecimiento humana recombinante (rhGH). Esta terapia ayuda a lograr patrones de crecimiento normales y a prevenir complicaciones asociadas con la baja estatura.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En casos de pubertad precoz, donde los ni\u00f1os experimentan un inicio temprano de la pubertad, se utilizan an\u00e1logos de la hormona liberadora de gonadotropina (GnRH) para retrasar un mayor desarrollo hasta una edad m\u00e1s apropiada. Estos tratamientos tienen como objetivo alinear la pubertad con la edad cronol\u00f3gica del ni\u00f1o, mitigando posibles problemas psicosociales y optimizando la altura final adulta.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Para j\u00f3venes transg\u00e9nero que experimentan disforia de g\u00e9nero, las pautas a menudo incluyen el uso de bloqueadores de la pubertad (an\u00e1logos de GnRH) para pausar el desarrollo de caracter\u00edsticas sexuales secundarias. Este retraso brinda tiempo para una mayor exploraci\u00f3n de la identidad de g\u00e9nero y reduce la angustia asociada con los cambios puberales no deseados. Posteriormente, se pueden administrar hormonas del sexo opuesto para alinear la apariencia f\u00edsica con la identidad de g\u00e9nero.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Controversias e inquietudes \u00e9ticas<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El uso de la terapia hormonal en poblaciones pedi\u00e1tricas est\u00e1 plagado de controversias, que giran principalmente en torno a los efectos a largo plazo y las implicaciones \u00e9ticas. Una preocupaci\u00f3n importante es el impacto potencial en la salud \u00f3sea y la fertilidad futura. Por ejemplo, el uso prolongado de an\u00e1logos de la GnRH puede provocar una disminuci\u00f3n de la densidad mineral \u00f3sea, lo que suscita interrogantes sobre el riesgo de osteoporosis en etapas posteriores de la vida.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La preservaci\u00f3n de la fertilidad es otro tema importante. Los bloqueadores de la pubertad y las hormonas cruzadas pueden afectar la fertilidad futura, lo que puede no ser una preocupaci\u00f3n principal durante la infancia, pero se vuelve crucial en la edad adulta. Los debates \u00e9ticos se centran en si los ni\u00f1os y adolescentes pueden comprender y consentir plenamente tratamientos que pueden influir en su potencial reproductivo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Impacto Psicosocial y Salud Mental<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El impacto psicosocial de la terapia hormonal en ni\u00f1os y adolescentes es una consideraci\u00f3n cr\u00edtica. Para los j\u00f3venes transg\u00e9nero, la terapia hormonal puede mejorar significativamente los resultados de salud mental al reducir la disforia de g\u00e9nero y el malestar asociado. Los estudios han demostrado que el acceso a la atenci\u00f3n de afirmaci\u00f3n de g\u00e9nero, incluida la terapia hormonal, est\u00e1 relacionado con tasas m\u00e1s bajas de depresi\u00f3n, ansiedad e ideaci\u00f3n suicida.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sin embargo, la decisi\u00f3n de iniciar la terapia hormonal, especialmente en ni\u00f1os peque\u00f1os, debe abordarse con precauci\u00f3n. Las evaluaciones psicol\u00f3gicas integrales y los equipos de atenci\u00f3n multidisciplinaria son esenciales para garantizar que se priorice el bienestar mental y emocional del ni\u00f1o. Este enfoque hol\u00edstico ayuda a equilibrar los beneficios de la terapia hormonal con la necesidad de apoyo psicol\u00f3gico y toma de decisiones informada.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Direcciones Futuras y Necesidades de Investigaci\u00f3n<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La investigaci\u00f3n en curso es crucial para abordar las lagunas de conocimiento sobre los efectos a largo plazo de la terapia hormonal pedi\u00e1trica. Se necesitan estudios longitudinales que rastreen los resultados de salud, la densidad \u00f3sea, la fertilidad y el bienestar psicol\u00f3gico hasta la edad adulta para ofrecer una imagen m\u00e1s clara de los riesgos y beneficios.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Adicionalmente, desarrollar enfoques personalizados para la terapia hormonal, considerando las diferencias individuales en gen\u00e9tica, estado de salud y factores psicosociales, puede mejorar la eficacia y seguridad del tratamiento. Los avances en medicina de precisi\u00f3n prometen adaptar las terapias hormonales a las necesidades \u00fanicas de cada ni\u00f1o.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Conclusi\u00f3n<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La terapia hormonal en poblaciones pedi\u00e1tricas ofrece beneficios significativos para el manejo de diversas afecciones m\u00e9dicas, pero est\u00e1 acompa\u00f1ada de complejos desaf\u00edos \u00e9ticos y m\u00e9dicos. Adherirse a las pautas establecidas, abordar los riesgos a largo plazo y garantizar un apoyo psicol\u00f3gico integral son esenciales para navegar estas controversias. Al continuar investigando y refinando los enfoques terap\u00e9uticos, la comunidad m\u00e9dica puede satisfacer mejor las necesidades de los ni\u00f1os y adolescentes que se someten a terapia hormonal.<\/p>","protected":false},"excerpt":{"rendered":"<p>Fase in libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci utet.<\/p>","protected":false},"author":1,"featured_media":15829,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":""},"categories":[118],"tags":[121,126,119,125,123,120],"class_list":["post-15827","post","type-post","status-publish","format-link","has-post-thumbnail","hentry","category-hrt-hormone-replacement-therapy","tag-estrogen","tag-hormonal-leveles","tag-hormones","tag-perimenopause","tag-testosterone","tag-therapy","post_format-post-format-link","pmpro-has-access"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hormone Therapy in Pediatric Populations: Guidelines and Controversies - Longevity Health Plans<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/longevityhealthplans.com\/es\/blog\/terapia-hormonal-en-poblaciones-pediatricas-guias-y-controversias\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hormone Therapy in Pediatric Populations: Guidelines and Controversies - Longevity Health Plans\" \/>\n<meta property=\"og:description\" content=\"Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci utet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/longevityhealthplans.com\/es\/blog\/terapia-hormonal-en-poblaciones-pediatricas-guias-y-controversias\/\" \/>\n<meta property=\"og:site_name\" content=\"Longevity Health Plans\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-26T07:57:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-26T07:57:38+00:00\" \/>\n<meta name=\"author\" content=\"Dawood\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dawood\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/\"},\"author\":{\"name\":\"Dawood\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#\\\/schema\\\/person\\\/efdcc4ff54b9490c9effb7f8fded56cd\"},\"headline\":\"Hormone Therapy in Pediatric Populations: Guidelines and Controversies\",\"datePublished\":\"2024-05-26T07:57:35+00:00\",\"dateModified\":\"2024-05-26T07:57:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/\"},\"wordCount\":602,\"image\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/866928.avif\",\"keywords\":[\"estrogen\",\"hormonal leveles\",\"hormones\",\"perimenopause\",\"testosterone\",\"therapy\"],\"articleSection\":[\"HRT | Hormone Replacement Therapy\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/\",\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/\",\"name\":\"Hormone Therapy in Pediatric Populations: Guidelines and Controversies - Longevity Health Plans\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/866928.avif\",\"datePublished\":\"2024-05-26T07:57:35+00:00\",\"dateModified\":\"2024-05-26T07:57:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#\\\/schema\\\/person\\\/efdcc4ff54b9490c9effb7f8fded56cd\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/866928.avif\",\"contentUrl\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/866928.avif\",\"width\":800,\"height\":534},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/longevityhealthplans.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hormone Therapy in Pediatric Populations: Guidelines and Controversies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#website\",\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/\",\"name\":\"Longevity Health Plans\",\"description\":\"Longevity Healthcare: Empowering Your Journey to Optimal Wellness\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/longevityhealthplans.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#\\\/schema\\\/person\\\/efdcc4ff54b9490c9effb7f8fded56cd\",\"name\":\"Dawood\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g\",\"caption\":\"Dawood\"},\"sameAs\":[\"https:\\\/\\\/webdevoceason.com\"],\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/es\\\/blog\\\/author\\\/hormonehealthplans-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Terapia Hormonal en Poblaciones Pedi\u00e1tricas: Gu\u00edas y Controversias - Longevity Health Plans","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/longevityhealthplans.com\/es\/blog\/terapia-hormonal-en-poblaciones-pediatricas-guias-y-controversias\/","og_locale":"es_MX","og_type":"article","og_title":"Hormone Therapy in Pediatric Populations: Guidelines and Controversies - Longevity Health Plans","og_description":"Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci utet.","og_url":"https:\/\/longevityhealthplans.com\/es\/blog\/terapia-hormonal-en-poblaciones-pediatricas-guias-y-controversias\/","og_site_name":"Longevity Health Plans","article_published_time":"2024-05-26T07:57:35+00:00","article_modified_time":"2024-05-26T07:57:38+00:00","author":"Dawood","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Dawood","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/#article","isPartOf":{"@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/"},"author":{"name":"Dawood","@id":"https:\/\/longevityhealthplans.com\/#\/schema\/person\/efdcc4ff54b9490c9effb7f8fded56cd"},"headline":"Hormone Therapy in Pediatric Populations: Guidelines and Controversies","datePublished":"2024-05-26T07:57:35+00:00","dateModified":"2024-05-26T07:57:38+00:00","mainEntityOfPage":{"@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/"},"wordCount":602,"image":{"@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/#primaryimage"},"thumbnailUrl":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/05\/866928.avif","keywords":["estrogen","hormonal leveles","hormones","perimenopause","testosterone","therapy"],"articleSection":["HRT | Hormone Replacement Therapy"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/","url":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/","name":"Terapia Hormonal en Poblaciones Pedi\u00e1tricas: Gu\u00edas y Controversias - Longevity Health Plans","isPartOf":{"@id":"https:\/\/longevityhealthplans.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/#primaryimage"},"image":{"@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/#primaryimage"},"thumbnailUrl":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/05\/866928.avif","datePublished":"2024-05-26T07:57:35+00:00","dateModified":"2024-05-26T07:57:38+00:00","author":{"@id":"https:\/\/longevityhealthplans.com\/#\/schema\/person\/efdcc4ff54b9490c9effb7f8fded56cd"},"breadcrumb":{"@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/#primaryimage","url":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/05\/866928.avif","contentUrl":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/05\/866928.avif","width":800,"height":534},{"@type":"BreadcrumbList","@id":"https:\/\/longevityhealthplans.com\/blog\/hormone-therapy-in-pediatric-populations-guidelines-and-controversies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/longevityhealthplans.com\/"},{"@type":"ListItem","position":2,"name":"Hormone Therapy in Pediatric Populations: Guidelines and Controversies"}]},{"@type":"WebSite","@id":"https:\/\/longevityhealthplans.com\/#website","url":"https:\/\/longevityhealthplans.com\/","name":"Longevity Health Plans","description":"Longevity Healthcare: Potenciando tu viaje hacia el bienestar \u00f3ptimo","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/longevityhealthplans.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/longevityhealthplans.com\/#\/schema\/person\/efdcc4ff54b9490c9effb7f8fded56cd","name":"Daud","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g","caption":"Dawood"},"sameAs":["https:\/\/webdevoceason.com"],"url":"https:\/\/longevityhealthplans.com\/es\/blog\/author\/hormonehealthplans-com\/"}]}},"_links":{"self":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts\/15827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/comments?post=15827"}],"version-history":[{"count":1,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts\/15827\/revisions"}],"predecessor-version":[{"id":15830,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts\/15827\/revisions\/15830"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/media\/15829"}],"wp:attachment":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/media?parent=15827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/categories?post=15827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/tags?post=15827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}